Concepedia

Heidi Van den Bulk

HV

1

Publications

12

Citations

1

H-Index

2019

Active since

Affiliations

CHU Dinant Godinne UCL Namur(Current)

Heidi Van den Bulk is an author at CHU Dinant Godinne UCL Namur specializing in cancer therapeutics, oncology, and radiation oncology.

Top concepts

Publications per year

2019–2019

1

Publications

1

Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)

Christel Fontaine, Vincent Renard, Heidi Van den Bulk et al. · Breast Cancer Research and Treatment · 2019 · 12 citations · Full text

, , +8

Rows per page

1–1 of 1